본문 바로가기
KERD
논문KCI 등재

양극산화 임플란트 표면에 적용된 헤파린과 골형성단백질(rhBMP-2)이 치조골 증대에 미치는 효과: 방사선학적 평가

Effect of immobilization of the recombinant human bone morphogenetic protein 2 (rhBMP-2) on anodized implants coated with heparin for improving alveolar ridge augmentation in beagle dogs: Radiographic observations

조재영|전영찬|정창모|윤미정|허중보|이소현
대한치과보철학회 (The Korean Academy Of Prosthodontics)|2013.10|대한치과보철학회지 (The Journal of Korean Academy of Prosthodontics)|제51권 제4호|pp. 307-314|DOI https://doi.org/10.4047/jkap.2013.51.4.307

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

도파민Dopamine골형성단백질양극산화 임플란트헤파린Anodized implantsHeparinBone morphogenetic protein
주제분류치의학

초록

연구 목적: 본 연구는 골형성단백질의 서방출을 위해 헤파린과 골형성단백질 (rhBMP-2)을 화학적으로 고정시킨 양극산화 티타늄 임플란트가 골 결손부에서 임플란트 주변의 수직적 골증대에 미치는 효과를 방사선학적으로 평가하고자 시행되었다. 연구 재료 및 방법: Pure-Titanium을 사용하여 길이 7.0 mm, 직경 3.5 mm의 실험용 임플란트 18개를 제작하였다. 모든 임플란트를 양극산화처리 하였고, 플랫폼 하방 2.5 mm에 식립 기준선을 표시하였다. rhBMP-2가 코팅되지 않은 임플란트 집단을 대조군으로, dip and dry 방법으로 rhBMP-2를 물리적 흡착시킨 집단을 BMP군, 3,4-dihydroxyphenylalanine (DOPA)-heparin을 이식하고 rhBMP-2를 화학적으로 고정시킨 집단을 Hep-BMP군으로 설정하였다. 각군별6개씩의 임플란트를 3마리의 비글견 양측 하악에 한 쪽에 3개씩 총 18개를 치조정 상방으로 2.5 mm 노출시켜 식립하였다. 식립 직후와 4주, 8주에 식립부위의 방사선학적 검사가 시행되었고, 각 시기별, 각 군별 임플란트의 근원심 변연골의 수직적 재생량에 대한 평균값과 표준편차를 얻었다. Kruskal-Wallis test와 Mann-Whitney U test를 이용하여 4주, 8주에서 대조군과 실험군들의 차이를 비교 분석하고, 유의 수준5%에서 통계적으로 검정하였다. 결과: 방사선학적 관찰 결과 임플란트 근원심 변연골 재생량(평균값 ± 표준편차)은 4주에 대조군은 0.09 ± 0.22 mm, BMP군은 1.02 ± 0.72 mm, Hep-BMP군은 1.29 ± 0.51 mm였으며, 8주에서는 각각 0.11 ± 1.26 mm, 1.11 ± 0.58 mm, 1.59 ± 0.79 mm였다. 두 실험군 모두 4주와 8주에서 대조군과 비교 시 유의한 수직적 골증대를 나타냈으나(P<.05), Hep-BMP군과BMP군의 비교에서는 유의한 변연골 재생량 차이를 보이지 않았다(P>.05). 결론: 골형성단백질을 물리적으로 흡착시키거나 서방출 위해 헤파린을 이용하여 화학적으로 고정시킨 양극산화 임플란트 표면은 모두 골 결손부에서 임플란트 주변골의 수직적 증대에 효과적이었다. 그러나 방사선학적 관찰의 한계 내에서 골형성단백질의 이 두가지 적용방법간에는 수직적 골증대량에 유의한 차이가 없었다.

Abstract

Purpose: The aim of this study was to evaluate the effect of immobilization of the recombinant human bone morphogenetic protein 2 (rhBMP-2) on anodized titaum implants coated with heparin to enhance the vertical alveolar ridge augmentation in the supraalveolar peri-implant defect region. Materials and methods: 18 pure titanium implants (7.0 mm in length, 3.5 mm in diameter) were manufactured for this study. All implants were anodized and designed insertion reference line marked with laser at the apical 2.5 mmfrom the fixture platform. Implantation of 6 noncoated anodized implants (Control group), 6 anodized implants physically adsorbed with rhBMP-2 by dip and dry method (BMP group) and 6 anodized implants chemically immobilized 3,4-dihydroxyphenylalanine (DOPA)-heparin/ rhBMP-2 (Hep-BMP group) was performed in the both mandibular of three male adult beagle dogs using split-mouth design. Radiologic examinations were performed immediately after implant placement and 4 and 8 weeks after implant placement. The amount of mesio-distal bone augmentation was evaluated by measuring the vertical distance from the platform to the marginal bone. Statistical analysis was performed using one-way analysis of variance (SPSS version 18.0) and multiple comparison analysis of The Kruskal-Wallis test and the Mann-Whitney U test. Statistical significance was established at the 5% significant level. Results: At the 4 weeks vertical alveolar ridge augmentation of Control group, BMP group and Hep-BMP group is 0.09 ± 0.22 mm, 1.02 ± 0.72 mm, and 1.29 ± 0.51 mm, At the 8 weeks 0.11 ± 1.26 mm, 1.11 ± 0.58 mm, 1.59 ± 0.79 mm according to radiographic observations. The two experimental groups showed a significantly increasing in vertical bone height compared with the control group (P<.05). However, there is no significant difference between the BMP group and Hep-BMP group (P>.05). Conclusion: The rhBMP-2 coated implants were enhanced the vertical bone growth in the supraalveolar peri-implant defect area. However, there is no significant difference between chemically and physically coating method.

참고문헌 (43)

  1. Junker R, "Effects of implant surface coatings and composition on bone integration: a systematic review", Clin Oral Implants Res, 20, pp.185~206 (2009)
  2. 허정보, "Physical stability of arginine-glycine-aspartic acid peptide coated on anodized implants after installation", The Journal of Advanced of Prosthodontics, 5(2), pp.84~91 (2013), 대한치과보철학회
  3. Rammelt S, "In vivo effects of coating loaded and unloaded Ti implants with collagen, chondroitin sulfate, and hydroxyapatite in the sheep tibia", J Orthop Res, 25, pp.1052~1061 (2007)
  4. Hall J, "Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model", J Clin Periodontol, 34, pp.444~451 (2007)
  5. Bessa PC, "Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts)", J Tissue Eng Regen Med, 2, pp.1~13 (2008)
  6. Bessa PC, "Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery)", J Tissue Eng Regen Med, 2, pp.81~96 (2008)
  7. Mehta M, "Biomaterial delivery of morphogens to mimic the natural healing cascade in bone", Adv Drug Deliv Rev, 64, pp.1257~1276 (2012)
  8. Boyne PJ, "A feasibility study evaluating rhBMP- 2", absorbable collagen sponge for maxillary sinus floor augmentation, 1997, pp.17, 11~25
  9. Hanisch O, "Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2", Int J Oral Maxillofac Implants, 12, pp.604~610 (1997)
  10. Howell TH, "A feasibility study evaluating rhBMP- 2", absorbable collagen sponge device for local alveolar ridge preservation or augmentation, 1997, pp.17, 124~139
  11. Sigurdsson TJ, "Periodontal repair in dogs: evaluation of rhBMP-2 carriers", Int J Periodontics Restorative Dent, 16, pp.524~537 (1996)
  12. Huh JB, "Alveolar ridge augmentation using anodized implants coated with Escherichia coli-derived recombinant human bone morphogenetic protein 2", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 112, pp.42~49 (2011)
  13. Stenport VF, "Titanium implants and BMP-7 in bone: an experimental model in the rabbit", J Mater Sci Mater Med, 14, pp.247~254 (2003)
  14. Schliephake H, "Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation", Clin Oral Implants Res, 16, pp.563~569 (2005)
  15. Stadlinger B, "Evaluation of osseointegration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study", Int J Oral Maxillofac Surg, 37, pp.54~59 (2008)
  16. Wikesjo¨ UM, "Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier", Clin Implant Dent Relat Res, 5, pp.112~123 (2003)
  17. Kim J, "Characterization of low-molecular-weight hyaluronic acid-based hydrogel and differential stem cell responses in the hydrogel microenvironments", J Biomed Mater Res A, 88, pp.967~975 (2009)
  18. Lee TC, "Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment", Neurosurgery, 58, pp.373~380 (2006)
  19. Gandhi NS, "Prediction of heparin binding sites in bone morphogenetic proteins (BMPs)", Biochim Biophys Acta, 1824, pp.1374~1381 (2012)
  20. Sasisekharan R, "On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans", Angiogenesis, 1, pp.45~54 (1997)
  21. Perets A, "Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres", J Biomed Mater Res A, 65, pp.489~497 (2003)
  22. 허중보, "The effect of immobilization of heparin and bone morphogenic protein-2 to bovine bone substitute on osteoblast-like cell’s function", The Journal of Advanced of Prosthodontics, 3(3), pp.145~151 (2011), 대한치과보철학회
  23. Kim SE, "The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function", Biomaterials, 32, pp.366~373 (2011)
  24. Ishibe T, "Bone formation on apatite-coated titanium with incorporated BMP-2", heparin in vivo, 2009, pp.108, 867~875
  25. Hong S, "Attenuation of the in vivo toxicity of biomaterials by polydopamine surface modification", Nanomedicine (Lond), 6, pp.793~801 (2011)
  26. Leknes KN, "Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations", Clin Oral Implants Res, 19, pp.1027~1033 (2008)
  27. Wikesjo¨ UM, "Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations", J Clin Periodontol, 35, pp.1001~1010 (2008)
  28. Huh JB, "Effects of anodized implants coated with Escherichia coli-derived rhBMP-2 in beagle dogs", Int J Oral Maxillofac Surg, 41, pp.1577~1584 (2012)
  29. 허중보, "양극산화 임플란트 표면에 적용된 골형성단백질과 혈관내피세포성장인자가 골유착에 미치는 영향: 예비연구", 대한치과보철학회지, 51(2), pp.82~89 (2013), 대한치과보철학회
  30. Boyne PJ, "De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation", J Oral Maxillofac Surg, 63, pp.1693~1707 (2005)
  31. Zhoua D, "Inorganic material surfaces made bioactive by immobilizing growth factors for hard tissue engineering", RSC Adv, 3, pp.11095~11106 (2013)
  32. Lee H, "Single-molecule mechanics of mussel adhesion", Proc Natl Acad Sci USA, 103, pp.12999~13003 (2006)
  33. Fan X, "Biomimetic anchor for surface-initiated polymerization from metal substrates", J Am Chem Soc, 127, pp.15843~15847 (2005)
  34. Lee H, "Mussel-inspired surface chemistry for multifunctional coatings", Science, 318, pp.426~430 (2007)
  35. Lai M, "Surface functionalization of TiO2 nanotubes with bone morphogenetic protein 2 and its synergistic effect on the differentiation of mesenchymal stem cells", Biomacromolecules, 12, pp.1097~1105 (2011)
  36. Lee DW, "Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration", Bone, 50, pp.974~982 (2012)
  37. Kempen DH, "Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering", Biomaterials, 29, pp.3245~3252 (2008)
  38. Kim SE, "Co-delivery of platelet-derived growth factor (PDGF-BB) and bone morphogenic protein (BMP-2) coated onto heparinized titanium for improving osteoblast function and osteointegration", J Tissue Eng Regen Med (2013)
  39. Takada T, "Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins", J Biol Chem, 278, pp.43229~43235 (2003)
  40. Zhao B, "Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein- 2", J Biol Chem, 281, pp.23246~23253 (2006)
  41. Koo KH, "Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits", Artif Organs, 37, pp.487~494 (2013)
  42. Rosen V, "BMP and BMP inhibitors in bone", Ann N Y Acad Sci, 1068, pp.19~25 (2006)
  43. Kaneko H, "Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts", Bone, 27, pp.479~486 (2000)

관련 논문AI추천

성견에서 골형성단백질이 코팅된 임플란트가 치조골 증대에 미치는 영향김종은, 류재준, 박찬경, 신상완, 신주희, 허중보대한치과보철학회 · 대한치과보철학회지2010 · 제48권 제03호양극산화 임플란트 표면에 적용된 골형성단백질과 혈관내피세포성장인자가 골유착에 미치는 영향: 예비연구신상완, 윤미정, 전영찬, 정창모, 허중보대한치과보철학회 · 대한치과보철학회지2013 · 제51권 제2호Recombinant human bone morphogenetic protein-2와 anorganic bovine bone 혼합이식 후치유과정에 관한 실험적 연구김영균, 박주철, 안교진치의학연구원 · Oral Biology Research2014 · 제38권 제2호성견 하악골에 식립한 다양한 임플란트 표면에서의 골 치유 양상에 관한 연구김용학, 박상원, 방몽숙, 양홍서, 임현필, 최홍란대한턱관절교합학회 · 구강회복응용과학지2009 · 제25권 제2호성견의 발치와 협측골 외측에 적용한 교원질 차단막과 재조합골형성단백질의 치조제 보존 효과김민수, 양혜주, 이중석, 임현창, 정의원, 최성호대한치과의사협회 · 대한치과의사협회지2015 · 제53권 제5호티타늄 임플란트의 표면처리가 골유착에 미치는 영향에 관한 조직형태계측학적 연구조인호, 최웅재대한치과보철학회 · 대한치과보철학회지2009 · 제47권 제4호

이 간행물의 다른 논문 (14건)

생체 내 티타늄과 지르코니아 표면에서 형성시킨 치면세균막의 비교이지현, 박소현, 김옥수, 임현필, 임규택, 임일구pp. 245-251하악 제1, 2대구치 단일 임플란트의 생존율에 관한 연구조진현, 이상한, 팽준영, 정택균pp. 252-260납형의 크기와 형태가 티타늄의 주조성에 미치는 영향이효일, 신유진, 박상원, 김홍주, 서윤정, 오계정pp. 261-268임플란트 길이, 직경 및 식립 위치에 따른 임플란트 안정성에 관한 후향적 연구김지혜, 전진용, 허유리, 손미경pp. 269-275기성 지대주와 맞춤형 CAD-CAM 지대주의 적합 및 나사 안정성 비교김종욱, 정재헌, 김희중, 허유리pp. 276-283
원문 보기